Related Experiment Videos
Carbohydrate metabolism in neoplastic tissue
Infusionstherapie Und Klinische Ernahrung
|April 1, 1986
Summary
Chicken tumor pyruvate kinase type M2 differs immunologically and kinetically from lung M2. Tumor enzyme
Area of Science:
- Biochemistry
- Enzymology
- Cancer Research
Background:
- Pyruvate kinase type M2 (PKM2) is a key glycolytic enzyme.
- PKM2 plays a role in cancer cell metabolism.
- Distinct PKM2 isoforms exist in normal and tumor tissues.
Purpose of the Study:
- To compare the kinetic and immunological properties of purified PKM2 from chicken lung and tumors.
- To investigate the functional differences of PKM2 in normal versus malignant cells.
Main Methods:
- Purification of homogeneous PKM2 from chicken lung and tumors.
- Enzyme kinetics assays including substrate affinity and allosteric regulation.
- Immunological characterization of PKM2 isoforms.
Main Results:
- PKM2 from lung and tumors are immunologically distinct.
- Tumor PKM2 exhibits low phosphoenol pyruvate affinity and is strongly activated by L-serine.
- Tumor PKM2 is significantly inhibited by amino acids like L-alanine and L-proline, unlike lung PKM2.
- Cellular amino acid concentrations differentially affect lung and tumor PKM2 activity.
Conclusions:
- The distinct properties of tumor PKM2 facilitate adaptation to altered metabolic demands in cancer.
- Tumor PKM2's regulation by amino acids supports energy production from glucose and amino acids.
- These findings highlight PKM2 as a potential target for cancer therapy.